Genopathy
Gene-Disorder Association · Article
Gene
PCSK9
Proprotein Convertase Subtilisin/Kexin Type 9
Manually curatedApproved treatment annotated
Association Review

In brief

The association between PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) and Familial Hypercholesterolemia is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording pathogenic and likely-pathogenic variants.

Sources 2
Clinical variants 789
Symptoms 0
Compounds 5
Trials 18of 165 via PCSK9 compounds
Publications 48
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

2 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
PCSK9

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Familial Hypercholesterolemia

The disorder

6 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
ClinVar and variant evidence

Genetic basis

789 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
06
Population genetics

GWAS signals

1 GWAS phenotype

Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.

Request access
07
Mechanism overlap

Shared mechanisms

1 shared pathway

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
08
Interventions

Therapeutics

5 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
09
Human studies

Clinical trials

165 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
10
Literature

Reading

48 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
11
Provenance

References & sources

18 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access